Scienza Health and Samsung Expand Care Across Galaxy Devices

digitalhumanOS™ and ERaaS™ platform delivers ambient speech screening, automated clinical workflows, and real-time monitoring across Samsung Galaxy ecosystem

NEWPORT BEACH, CA — Scienza Health and Samsung announced a collaboration delivering advanced patient screening, engagement, and monitoring through Galaxy smartwatches, phones, tablets, and TVs — making the FDA-registered digitalhumanOS™ and ERaaS™ (Exam Room as a Service) platform accessible across Samsung’s Galaxy ecosystem.

The platform uses ambient speech analysis and real-time biometric data to support cognitive and neurological health screenings, automate clinical workflows, and improve patient and provider experience — at home, in clinics, and across care communities.

The program launched in October 2025 with rollout to skilled-nursing facilities, assisted living communities, health systems, and home care providers.

Covered by McKnight’s Senior Living, Morningstar, AI Journal, and Samsung Global Newsroom.

Source: BusinessWire, October 22, 2025.

Related: Scienza Health co-chaired the Samsung Frontline Worker Innovation Summit in August 2025.

Media contact: press@scienzahealth.com

About Scienza Health

Scienza Health builds digitalhumanOS™ and GIA® — the world’s first cleared digital human and clinical AI operating system purpose-built for post-acute and long-term care. GIA® screens for 46 clinical conditions using Voice AI, Computer Vision, and Speech Biomarkers in a single patient conversation lasting under five minutes. The platform is powered by 12.3 million longitudinal PAC/LTC patient records and 27 billion clinical events. FDA-registered. HIPAA compliant. Bundled on Samsung Health Grade Galaxy devices. Headquartered in Newport Beach, California.

Note to editors: digitalhumanOS™ and GIA® are trademarks of Scienza Health, Inc. All other trademarks are the property of their respective owners.